Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study.
de Lédinghen V, Ratziu V, Causse X, Le Bail B, Capron D, Renou C, Pilette C, Oules V, Gelsi E, Oberti F, Vallet-Pichard A, Le Provost N, Cadranel JF; Association Française pour l'Etude du Foie Groupe Epidémiologie et Evaluation; Association Nationale des Gastroentérologues des Hôpitaux généraux de France. de Lédinghen V, et al. Among authors: renou c. J Hepatol. 2006 Oct;45(4):592-9. doi: 10.1016/j.jhep.2006.05.008. Epub 2006 Jun 16. J Hepatol. 2006. PMID: 16837098 Clinical Trial.
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis.
Ratziu V, de Ledinghen V, Oberti F, Mathurin P, Wartelle-Bladou C, Renou C, Sogni P, Maynard M, Larrey D, Serfaty L, Bonnefont-Rousselot D, Bastard JP, Rivière M, Spénard J; FRESGUN. Ratziu V, et al. Among authors: renou c. J Hepatol. 2011 May;54(5):1011-9. doi: 10.1016/j.jhep.2010.08.030. Epub 2010 Oct 31. J Hepatol. 2011. PMID: 21145828 Clinical Trial.
Optimized stepwise combination algorithms of non-invasive liver fibrosis scores including Hepascore in hepatitis C virus patients.
Bourliere M, Penaranda G, Ouzan D, Renou C, Botta-Fridlund D, Tran A, Rosenthal E, Wartelle-Bladou C, Delasalle P, Oules V, Portal I, Castellani P, Lecomte L, Rosenthal-Allieri MA, Halfon P. Bourliere M, et al. Among authors: renou c. Aliment Pharmacol Ther. 2008 Aug 15;28(4):458-67. doi: 10.1111/j.1365-2036.2008.03742.x. Epub 2008 May 22. Aliment Pharmacol Ther. 2008. PMID: 18498446 Free article.
A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis.
Ratziu V, Sheikh MY, Sanyal AJ, Lim JK, Conjeevaram H, Chalasani N, Abdelmalek M, Bakken A, Renou C, Palmer M, Levine RA, Bhandari BR, Cornpropst M, Liang W, King B, Mondou E, Rousseau FS, McHutchison J, Chojkier M. Ratziu V, et al. Among authors: renou c. Hepatology. 2012 Feb;55(2):419-28. doi: 10.1002/hep.24747. Epub 2011 Dec 14. Hepatology. 2012. PMID: 22006541 Free PMC article. Clinical Trial.
Treatment of chronic hepatitis C with pegylated interferon and ribavirin in treatment-naive patients in 'true life': a plea in favor of independent postmarketing evaluations.
Pariente A, Lahmek P, Duprat C, Denis J, Faroux R, Renou C, Nalet B, Morin T, Cadranel JF; Investigator Group belonging to Association Nationale des Gastroentérologues des Hôpitaux Généraux (ANGH). Pariente A, et al. Among authors: renou c. Eur J Gastroenterol Hepatol. 2010 Nov;22(11):1297-302. doi: 10.1097/meg.0b013e32833bb4b0. Eur J Gastroenterol Hepatol. 2010. PMID: 20964260
Impact of IL28B on the treatment decision in naïve and experienced patients with genotype 1 and 4 chronic hepatitis C in real-life clinical practice: a prospective multicenter cohort.
Halfon P, Ouzan D, Asselah T, Renou C, Allègre T, Delasalle P, Lafeuillade A, Cadranel JF, Haddad N, Khiri H, Pénaranda G, Bourlière M; Iliade Investigators. Halfon P, et al. Among authors: renou c. Clin Res Hepatol Gastroenterol. 2014 Dec;38(6):720-6. doi: 10.1016/j.clinre.2014.06.004. Epub 2014 Jul 14. Clin Res Hepatol Gastroenterol. 2014. PMID: 25034356
Hepatogastroenterologists' knowledge of inactive carriers and immunotolerant hepatitis B virus patients in France: results of a practice survey.
Causse X, Cadranel JF, Potier P, Hanslik B, Denis J, Renou C, Delasalle P; Club de Réflexion des Cabinets et Groupes d’Hépato-Gastroentérologie (CREGG); Association Nationale des hépato-Gastroentérologues des Hôpitaux généraux de France (ANGH). Causse X, et al. Among authors: renou c. Eur J Gastroenterol Hepatol. 2015 May;27(5):544-9. doi: 10.1097/MEG.0000000000000306. Eur J Gastroenterol Hepatol. 2015. PMID: 25822863
Efficacy and safety of treatment of chronic hepatitis C with sofosbuvir and ribavirin with or without peginterferon: a French prospective real-life cohort study of unselected 211 patients.
Garioud A, Heng R, Amiot X, Rémy AJ, Ollivier-Hourmand I, Mokhtari C, Medmoun M, Renou C, Zougmoré H, Pulwermacher P, Lucidarme D, Rosa-Hézode I, Causse X, Arotcarena R, Zanditenas D, Halfon P, Pariente A, Cadranel JF; Association Nationale des Hépato-gastroentérologues des Hôpitaux Généraux (ANGH), France. Garioud A, et al. Among authors: renou c. Eur J Gastroenterol Hepatol. 2019 Oct;31(10):1270-1274. doi: 10.1097/MEG.0000000000001450. Eur J Gastroenterol Hepatol. 2019. PMID: 31219848 Clinical Trial.
104 results